US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Dick Taylor Craft Chocolate Issues Recall for Allergy Allert on Undeclared Peanuts in “Ginger Snap Milk Chocolate”

      Summary Company Announcement Date: September 28, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Baxter Issues Urgent Medical Device Correction Regarding Potential Radio Frequency Interference With Other Devices Near Beds Installed With WatchCare System

Baxter Issues Urgent Medical Device Correction Regarding Potential Radio Frequency Interference With Other Devices Near Beds Installed With WatchCare System

October 20, 2022 By The FDA Leave a Comment

Summary

Company Announcement Date:
October 21, 2022
FDA Publish Date:
October 24, 2022
Product Type:
Medical Devices

Reason for Announcement:

Recall Reason Description

Potential for radio frequency (RF) interference with other medical devices.

Company Name:
Baxter International Inc.
Brand Name:

Brand Name(s)

Product Description:

Product Description

Incontinence management system


Company Announcement

Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for the WatchCare Incontinence Management System due to potential for radio frequency (RF) interference with other medical devices. The WatchCare system is designed to discreetly alert the caregiver of an incontinence event. Although the WatchCare system has been developed to comply with the most recent RF standards, it radiates RF that might affect other devices in the vicinity, including devices on both patients and staff members. This RF interference could result in erroneous readings or additional malfunctions of these other devices and could therefore result in inappropriate medical intervention. Depending on the intended use of the device that malfunctions, there may be different hazardous situations that could occur. This product is manufactured by Hillrom, which was acquired by Baxter in late 2021.

Baxter is also issuing an updated customer notification letter for this correction, replacing the previous letter issued on September 30, 2022.

To date, interference in all cases but two is known to have occurred at distances less than one meter. There is insufficient data about distance on the remaining two reported interferences. Of note, Baxter is informing users of the following potential hazards, though additional devices may be affected:

  • Insulin pump/blood glucose sensor: Sensor readings can be affected and result in overdosing of insulin related to incorrect high glucose readings; as a precaution, users should be vigilant of any erratic or incorrect (high or low) glucose level(s) or insulin dosing events
  • Fetal monitor/doppler: May cause “phantom” incorrect fetal heart tone readings up to 200 bpm; as a precaution, users should be vigilant of any erratic or incorrect (high or low) fetal heart tones
  • Telemetry devices: Could cause telemetry “artifact” of unknown specificity; as a precaution, users should be vigilant of any telemetry rhythm displays that do not match patient’s clinical presentation
  • Bladder scanner: May cause interference of unknown specificity; as a precaution, users should be vigilant of any potential false (elevated or low) residual urine volume readings
  • Infusion injection pump: May cause interference of unknown specificity; as a precaution, users should be vigilant of any erratic or incorrect dosing events

Since this issue may affect blood glucose sensors, insulin pumps, fetal monitors, and general infusion pumps among other devices, serious harm or death may occur. This issue can affect medical devices on patients as well as staff caring for patients. No serious injuries or deaths have been reported.

Users and facilities should immediately locate all affected devices and stop use of all WatchCare system accessories where possible until this functionality is temporarily disabled and while Baxter continues to work to determine the cause of this problem. Baxter will contact users to arrange for WatchCare to be temporarily disabled.

Until all RF capabilities are disabled and/or all devices are removed from clinical care areas, be aware that RF emission from a functioning WatchCare device may potentially impact other devices (including, but not limited to, insulin pumps/blood glucose sensors, fetal monitor/dopplers, infusion pumps, telemetry devices, and bladder scanners). Please double-check all unexpected or atypical results and monitor infusions closely, if possible. Until this issue is resolved, use standard, non-RF-based, incontinence management pads.

Baxter is monitoring reports of RF interference and validating the impact the WatchCare device may have on other devices in the vicinity. Baxter is also investigating improvement opportunities and will provide a follow-up communication to users once available.

This Urgent Medical Device Correction applies to Centrella Bed with WatchCare product number P7900B; WatchCare System for VersaCare Bed Rev. A-J product number P00697901; WatchCare System for VersaCare Bed Rev. K product number P00697902; WatchCare System for Progressa Bed product number P00697903; and WatchCare System for Centrella Bed product number P00697905.

The WatchCare System is distributed in the United States. Customers with additional questions can contact Hillrom Technical Support by phone at 800-445-3720 or by email at [email protected]. Any adverse events experienced with the use of this product may be reported using one of the following options:

Baxter is voluntarily issuing this Urgent Medical Device Correction with the knowledge of the U.S. Food and Drug Administration.

About Baxter

Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.

Baxter, Hillrom, WatchCare, Centrella, VersaCare and Progressa are registered trademarks of Baxter International Inc. or its subsidiaries.


Company Contact Information

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Dick Taylor Craft Chocolate Issues Recall for Allergy Allert on Undeclared Peanuts in “Ginger Snap Milk Chocolate”

September 27, 2023 By The FDA

Penzeys Spices Issues Allergy Alert on Undeclared Sesame Seeds in “Brady Street Cheese Sprinkle”

September 27, 2023 By The FDA

Trek Recalls Allant+ 7 Bicycles Due to Crash Hazard

September 27, 2023 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Rust-Oleum Recalls Fluorescent Pink Spray Paint Due to Injury Hazard

September 27, 2023 By The CPSC

Secura Recalls Air Fryers Due to Fire and Burn Hazards (Recall Alert)

September 27, 2023 By The CPSC

Polaris Recalls Ranger Recreational Off-Highway Vehicles and Pro XD Utility Vehicles, Gravely ATLAS Utility Vehicles, and Bobcat Utility Vehicles Due to Injury Hazard (Recall Alert)

September 27, 2023 By The CPSC

SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) Due to Potential for Cross Contamination with a Non-Antibacterial ßlactam Drug Substance

September 26, 2023 By The FDA

Eagle Produce LLC Recalls Whole Cantaloupe Because of Possible Health Risk

September 26, 2023 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) Due to Potential for Cross Contamination with a Non-Antibacterial ßlactam Drug Substance

September 26, 2023 By The FDA

Eagle Produce LLC Recalls Whole Cantaloupe Because of Possible Health Risk

September 26, 2023 By The FDA

Safeway Fresh Foods Recalls Sunnyside Farms Organic Butternut Squash Because of Possible Health Risk

September 24, 2023 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Dick Taylor Craft Chocolate Issues Recall for Allergy Allert on Undeclared Peanuts in “Ginger Snap Milk Chocolate”
  • Penzeys Spices Issues Allergy Alert on Undeclared Sesame Seeds in “Brady Street Cheese Sprinkle”
  • Trek Recalls Allant+ 7 Bicycles Due to Crash Hazard
  • Procter & Gamble Recalls Zevo Fly, Gnat and Fruit Fly Insect Spray Due to Injury and Laceration Hazards
  • Nutraceutical Recalls Solaray Liposomal Multivitamins Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
  • Rust-Oleum Recalls Fluorescent Pink Spray Paint Due to Injury Hazard
  • Secura Recalls Air Fryers Due to Fire and Burn Hazards (Recall Alert)
  • Polaris Recalls Ranger Recreational Off-Highway Vehicles and Pro XD Utility Vehicles, Gravely ATLAS Utility Vehicles, and Bobcat Utility Vehicles Due to Injury Hazard (Recall Alert)
  • SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) Due to Potential for Cross Contamination with a Non-Antibacterial ßlactam Drug Substance
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in